Dopamine D2/D3 receptors drugs for Parkinson's Disease
2 tracked Dopamine D2/D3 receptors drugs in the Parkinson's Disease race. The class explanation lives on the Dopamine D2/D3 receptors page; the full indication pipeline across every mechanism is on the Parkinson's Disease page.
1 approved / phase 41 US approval withdrawn